|
|
|
Insider
Information: |
Fuchs Henry J |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
222,228 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$18,063,061 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
222,228 |
|
|
Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
294 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 10 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-03-15 |
4 |
D |
$92.50 |
$473,230 |
D/D |
(5,116) |
120,402 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2016-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
19,790 |
120,666 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2016-04-29 |
4 |
A |
$51.26 |
$21,275 |
D/D |
415 |
121,081 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2020-04-20 |
4 |
AS |
$90.00 |
$1,549,170 |
D/D |
(17,213) |
122,656 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2019-03-25 |
4 |
AS |
$87.86 |
$521,186 |
D/D |
(5,932) |
124,536 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2019-04-30 |
4 |
A |
$68.78 |
$21,254 |
D/D |
309 |
124,845 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-03-03 |
4 |
D |
$93.95 |
$274,710 |
D/D |
(2,924) |
125,518 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2020-07-13 |
4 |
OE |
$63.10 |
$1,518,094 |
D/D |
23,011 |
126,006 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2020-03-13 |
4 |
D |
$84.50 |
$886,912 |
D/D |
(10,496) |
127,485 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
14,564 |
128,442 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-02-24 |
4 |
AS |
$87.99 |
$1,319,850 |
D/D |
(15,000) |
128,442 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2016-08-26 |
4 |
OE |
$26.49 |
$397,350 |
D/D |
15,000 |
128,878 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2016-11-25 |
4 |
OE |
$26.49 |
$397,350 |
D/D |
15,000 |
128,878 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2015-03-16 |
4 |
OE |
$21.51 |
$860,400 |
D/D |
40,000 |
129,950 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2018-08-27 |
4 |
S |
$100.00 |
$1,250,000 |
D/D |
(12,500) |
130,167 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2019-03-22 |
4 |
D |
$88.05 |
$513,860 |
D/D |
(5,836) |
130,468 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2016-05-26 |
4 |
OE |
$26.49 |
$397,350 |
D/D |
15,000 |
130,914 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2019-03-15 |
4 |
D |
$94.53 |
$892,647 |
D/D |
(9,443) |
133,061 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2018-01-02 |
4 |
AS |
$89.23 |
$1,338,401 |
D/D |
(15,000) |
133,976 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2019-03-18 |
4 |
AS |
$94.09 |
$902,982 |
D/D |
(9,597) |
136,304 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-06-02 |
4 |
D |
$90.72 |
$184,706 |
D/D |
(2,036) |
136,422 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-06-16 |
4 |
AS |
$90.00 |
$1,295,730 |
D/D |
(14,397) |
136,422 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-06-19 |
4 |
AS |
$90.00 |
$54,270 |
D/D |
(603) |
136,422 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-09-15 |
4 |
AS |
$90.50 |
$1,357,500 |
D/D |
(15,000) |
136,422 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-06-19 |
4 |
OE |
$37.46 |
$22,588 |
D/D |
603 |
137,025 |
0 |
- |
|
294 Records found
|
|
Page 10 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|